Siam Bioscience focuses on research, development and manufacturing of biopharmaceuticals, pharmaceuticals, medical devices, and related healthcare products. The company conducts comprehensive R&D and manufacturing starting from active pharmaceutical ingredients and biological active substances to final dosage forms and finished products.
• Apexcela focuses on sales, marketing, and distribution of Siam Bioscience products, including business development aiming to build partnerships both in Thailand and worldwide.
Our main objective is to manufacture biopharmaceuticals using state-of-the-art and efficient technology. Biopharmaceuticals can treat many diseases effectively with low side effects. Our companies have started producing and commercializing biopharmaceuticals since 2016, launching erythropoietin for anemia and filgrastim for neutropenia. Our plant achieved PIC/s GMP, and ISO17025:2016. Our products are available through all reimbursement schemes in Thailand
Our world-class quality standards and comprehensive R&D coupled with business development capabilities have led us to be awarded contract development and manufacturing agreements of medicines and medical devices for various organizations, both in Thailand and worldwide.
In 2017, Siam Bioscience Group expanded business further by establishing 2 subsidiaries.
• Abinis Co., Ltd. is the joint venture company with CIMAB (Cuba) for R&D, manufacturing, and commercialization of mammalian cell culture derived biopharmaceuticals for treatment of various diseases such as cancer, autoimmune diseases, and anemia with focus on exportation.
• Inno Biocosmed Co., Ltd. is a wholly-owned subsidiary of Siam Bioscience for commercialization of biocosmeceuticals which are developed and manufactured by Siam Bioscience Group.
Production Officer is responsible for supporting the production process in accordance with GMP standards and ensuring the proper management of chemicals and equipment.
